Skip to content

News archive

"The results promising and we look forward to the publication of the study" says Lina Olsson, CEO of Umeå based HiloProbe.

New promising data with ColoNode for colon cancer

Umeå University has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode's benefits and usefulness in colon cancer.

Omnio's Research engineer Assar Bäckman makes his last day at work today. Assar has been an indispensable part of both Omnio and Umeå Biotech Incubator for the last 20 years.

Assar Bäckman hangs up his lab coat and looks forward to retirement

He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire. “My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.

The development project is being conducted av RISE in Örnsköldsvik. Daniel Pacurar, Boreal Orchards, and Frida Sandberg, research- and development engineer at RISE, look forward to the results.

New collaboration hopes to make the most out of moss

The Umeå Biotech Incubator-backed ‘Shades of Green’ project, developed by Boreal Orchards, has created a moss that can be used on buildings, infrastructure and for the regeneration of nature. Now founder Daniel Pacurar is collaborating on a new development project with RISE Processum AB and Ecohelix to maximize moss establishment with the help of by-products from the paper pulp industry.

QureTech Bio Appoints Three New Board Members to Strengthen Drug and Business Development

QureTech Bio Appoints Three New Board Members to Strengthen Drug and Business Development

QureTech Bio AB (QTB), a pharmaceutical development company originating from Umeå University, proudly announces the appointment of three new board members at its Annual General Meeting held on May 25, 2023. This strategic move is aimed at further enhancing QTB's drug and business development.
The newly appointed board members are:
Yijing Sun Hultgren
Yijing has over a decade of experience

Maria Sundell, senior consultant at Orderly People, starts working in Umeå after the summer. "It will be exciting to be able to offer my skills to local companies", she says.

MedTech consultant company establishes in Umeå

Life science consulting company Orderly People has announced it will base one of its consultants in Umeå after the summer. “There is a vibrant life science industry in Umeå which we want to be a part of”, says Orderly People's founder and co-owner, Maria Jansson.

Ulrika Norin is the CEO of Umeå based Omnio AB and Tomas Eriksson is the new Chairman of the Board. This week Omnio gives a presentation on its treatment method at the European Wound Management Association annual meeting in Milan, Italy.

New international board promises to take Omnio to the next level

Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.

Show more

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden